From March 1986 to October 1989, 91 @entity1 underwent CABG using the right @entity432 ( @entity432 ) at Osaka Medical College and Mitsui Memorial Hospital. Including 14 females, the mean age was 57.9 years old ranged from 34 to 73 years old. @entity66 and left main disease occupied over 90% of the @entity1 . There were 5 emergency operations and 6 reoperations. Associated serious diseases were; @entity177 with hemodialysis in 2 pts., @entity407 in 5 pts., severe @entity731 ascending aorta in 8 pts., @entity4288 obliterance in 3 pts., and each one of @entity1028 and @entity3039 . The internal thoracic artery (ITA) graft was concomitantly utilized in 96% of the @entity1 . Single ITA in 60 pts., double ITA in 23 pts. and sequential ITA in 5 @entity1 . Saphenous vein graft was used in 58 @entity1 and remaining 33 @entity1 were operated without leg wound. The mean number of distal anastomoses was 3.3 ranged from 1 to 5, and the mean number of arterial grafts was 2.5 ranged from 1 to 4. The mean aortic cross clamp time and cardiopulmonary bypass time was 62.8 minutes and 113.6 minutes, respectively. Sites of @entity432 @entity254 were; 4 anterior descending, 3 diagonal, 11 circumflex and 73 right coronary arteries. There were 86 in situ grafts mostly for the right coronary arteries, and remaining 5 GEAs were used as a free graft to bypass the left coronary arteries. On the contrary, ITA was used to bypass the left coronary artery system preferentially. There was 3 combined procedures; splenectomy, abdominal aorta replacement, and ascending aorta to bifemoral artery bypass in each one @entity1 . Three @entity1 including one emergency case died within 30 days after surgery. Two were cardiac and one was @entity177 . Other 2 @entity1 died of @entity64 at late period. New Q wave @entity1188 was noted in 2 @entity1 . Relief of angina was obtained in 98% of survivors. The patency rate of the @entity432 graft was 97% in 61 grafts restudied within 6 postoperative months, which was identical with that of the ITA graft, that is 97% of 76 grafts. In conclusion, the @entity432 has several advantages as a coronary artery bypass graft such as similarity in size to the coronary artery, rare @entity4288 , feasibility of in situ graft, and no @entity1819 . Its flow capacity is studying now and favourable results are being obtained. The final problem, its long term patency, will be resolved in future. @entity432 is a promising conduit for the coronary bypass surgery.

[The XXXX graft in coronary artery bypass surgery].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity407 :: ('MESH:D006949', 'Disease') :: ['familial hyperlipidemia'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke'] @entity66 :: ('MESH:D004194', 'Disease') :: ['Triple vessel disease'] @entity3039 :: ('MESH:D016553', 'Disease') :: ['idiopathic thrombocytopenic purpura'] @entity1819 :: ('MESH:D013272', 'Disease') :: ['gastric complication'] @entity254 :: ('MESH:C563598', 'Disease') :: ['anastomosis'] @entity177 :: ('MESH:D051437', 'Disease') :: ['renal failure'] @entity1188 :: ('MESH:D007238', 'Disease') :: ['infarction'] @entity432 :: ('MESH:D001157', 'Disease') :: ['gastroepiploic artery', 'GEA'] @entity731 :: ('MESH:D050197', 'Disease') :: ['atherosclerotic'] @entity1028 :: ('MESH:D017544', 'Disease') :: ['abdominal aortic aneurysm'] @entity4288 :: ('MESH:D001161', 'Disease') :: ['arteriosclerosis']
@entity432 :: (MESH:D001157,Disease) :: ['gastroepiploic artery']
